从试验结果来看，脐带血干细胞移植是有希望的。
Results from cord blood stem cell transplants are promising.
数千份脐带血干细胞移植被用来治愈患有血液或免疫力疾病的孩子。
Thousands of successful umbilical cord blood stem cell transplants have already been carried out to treat children with severe blood conditions or immune disorders.
这也就是为什么当我们出生后，胎盘及脐带血能够用作造血干细胞移植的来源。
That is why, after birth, placental and umbilical cord blood can be used as a source of stem cells for transplantation.
捐赠脐带血和捐赠骨髓不一样，移植干细胞不需要寻找配对，所以有更多白血病和其他疾病的患者可以获救。
Placental blood donations differ from bone marrow donations, in that stem cells can be transplanted without the need to find a match. Thus more patients with leukemia and other diseases can be saved.
脐带血干细胞的保存及脐带血移植等临床应用均取得了显著的进展，但也面临许多问题。
The preservation of cord blood stem cells and umbilical cord blood transplantation, and other clinical applications have made significant progress, but blood is also facing many problems.
背景：对于造血干细胞同种异体移植，当不能得到匹配的同胞供体时，一份库存的供体脐带血可能是很有价值的资源。
BACKGROUND: a stored cord blood donation may be a valuable source of hemopoietic stem cells for allogeneic transplantation when a matched sibling donor is not available.
脐带血富含造血祖细胞，既可作为造血干细胞移植新的来源，又可用于骨髓抑制患者的临床输注，有广阔的应用前景。
The umbilical cord blood included much more hematopoietic progenitor cells. The umbilical cord blood provided new source for hematopoietic cells transplantation and t...
脐带血富含造血祖细胞，既可作为造血干细胞移植新的来源，又可用于骨髓抑制患者的临床输注，有广阔的应用前景。
The umbilical cord blood included much more hematopoietic progenitor cells. The umbilical cord blood provided new source for hematopoietic cells transplantation and t...
应用推荐